Picture of China Regenerative Medicine International logo

8158 China Regenerative Medicine International Income Statement

0.000.00%
hk flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual income statement for China Regenerative Medicine International, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.

R2019
December 31st
R2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSPRESS
Standards:
HKAS
HKAS
HKAS
HKAS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue19.418228323269.5
Cost of Revenue
Gross Profit4.641.867.737.619.4
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses335209259223176
Operating Profit-316-26.523.79.05-107
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-322-14264.38.27-108
Provision for Income Taxes
Net Income After Taxes-317-15451.84.55-108
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income-395-40413.34.55-108
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-395-40413.34.55-108
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-1.46-0.7640.1680.014-0.376
0